Ozempic Sales Up 58% As Drugmaker Novo Nordisk Nets Record P

Revenue for the Danish company behind the booming GLP-1 injectable drugs is up 29% so far this year.

Related Keywords

United States , Denmark , American , Danish , America , Forbeswill Ozempic , Novo Nordisk , European Stoxx , Ozempic Kill Donut , Ozempic , Wegovy , Glp 1s , Ozempic Sales , Ozempic Stocks ,